USPTO serial 79341760
HFL HEALTH FIRST LABORATORIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 31, 2023
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HFL HEALTH FIRST LABORATORIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bradley M. Stohry
Bradley M. Stohry Reichel Stohry Dean LLP525 S. Meridian St., Suite 1A2Indianapolis, IN 46225UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical testing apparatus, namely, blood testing and monitoring apparatus, medical diagnostic apparatus for testing fecal immunochemical levels, medical diagnostic apparatus for testing gluten intolerance, medical diagnostic apparatus for testing for human papillomavirus, medical diagnostic apparatus for testing for bacteriological disease, medical diagnostic apparatus for bowel cancer screening, medical diagnostic apparatus for lateral flow immunoassay testing and medical diagnostic apparatus for viral disease screening; home and self-testing apparatus, equipment and instruments for medical use, namely, blood testing and monitoring apparatus, medical diagnostic apparatus for testing fecal immunochemical levels, medical diagnostic apparatus for testing gluten intolerance, medical diagnostic apparatus for testing for human papillomavirus, medical diagnostic apparatus for testing for bacteriological disease, medical diagnostic apparatus for bowel cancer screening, medical diagnostic apparatus for lateral flow immunoassay testing and medical diagnostic apparatus for viral disease screening; home and self-testing kits for medical use comprised of blood testing and monitoring apparatus, medical diagnostic apparatus for testing fecal immunochemical levels, medical diagnostic apparatus for testing gluten intolerance, medical diagnostic apparatus for testing for human papillomavirus, medical diagnostic apparatus for testing for bacteriological disease, medical diagnostic apparatus for bowel cancer screening, medical diagnostic apparatus for lateral flow immunoassay testing and medical diagnostic apparatus for viral disease screening; lateral flow testing apparatus for medical use for detecting coronavirus (COVID-19) comprised of nasal mucus testing apparatus; medical sampling apparatus for blood testing and blood monitoring, for testing fecal immunochemical levels, for testing gluten intolerance, for testing for human papillomavirus, for testing for bacteriological disease, for bowel cancer screening, for lateral flow immunoassay testing and for viral disease screening; lateral flow test kits for medical use for detecting coronavirus (COVID-19) comprised of nasal mucus testing apparatus; medical testing apparatus, equipment and instruments for bowel cancer screening; medical sampling apparatus, equipment and instruments for bowel cancer screening; medical apparatus, equipment and instruments for viral disease screening; faecal immunochemical testing apparatus, equipment and instruments for medical use; home and self-testing faecal immunochemical testing apparatus, equipment and instruments for medical use; gluten intolerance testing apparatus, equipment and instruments for medical use; home and self-testing gluten intolerance testing apparatus, equipment and instruments for medical use; human papillomavirus testing apparatus, equipment and instruments for medical use; home and self-testing human papillomavirus testing apparatus, equipment and instruments for medical use; apparatus, equipment and instruments for blood monitoring for medical use; medical sampling tubes, namely, blood and medical specimen sampling tubes | ACTIVE | — |
| 035 | On-line retail store services featuring diagnostic testing kits, medical testing kits, medical in-home testing kits, blood testing apparatus, medical testing apparatus, including blood testing apparatus, medical immunochemical testing apparatus, fecal immunochemical testing kits, gluten intolerance testing kits, human papillomavirus testing kits, bowel cancer screening kits, lateral flow immunoassay testing kits and viral disease screening kits; Retail stores featuring diagnostic testing kits, medical testing kits, medical in-home testing kits, blood testing apparatus, medical testing apparatus, including blood testing apparatus, medical immunochemical testing apparatus, fecal immunochemical testing kits, gluten intolerance testing kits, human papillomavirus testing kits, bacteriological disease testing kits, bowel cancer screening kits, lateral flow immunoassay testing kits and viral disease screening kits; information, advisory and consultancy services relating to all of the aforementioned services | ACTIVE | — |
| 042 | Laboratory research in the field of medical testing; Medical laboratory services for analytical testing; laboratory analysis in the field of medical testing; electronic data storage; electronic storage of medical information and records; providing search engines for obtaining data via communications networks; information, advisory and consultancy services relating to all of the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Health First Laboratories Ltd
- Other trademarks owned by Health First Laboratories Ltd
- Other trademarks owned by Health First Laboratories Ltd
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named HFL HEALTH FIRST LABORATORIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 2, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 2, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 31, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 21, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 15, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 15, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 2, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 2, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 26, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 10, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 10, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 28, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 18, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 18, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 18, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 17, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 17, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 5, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 15, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 15, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 9, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 8, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 3, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 2, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |